New Delhi : Drug firm Wockhardt reported over five-fold jump in its consolidated net profit at Rs 114.20 crore for the quarter ended June 30 mainly on account of robust sales. The company had posted a net profit after taxes, minority interest and share of profit of associates at Rs 19.95 crore for the corresponding period of the previous fiscal, Wockhardt said in a filing to the BSE. Consolidated total income also rose to Rs 1,140.65 crore as against Rs 991.19 crore for the same period a year ago. Wockhardt has 12 manufacturing plants in India, Britain, Ireland and the US and employs 607 scientists in three global research centres.
Wockhardt Q1 net zooms 5-fold
RECENT STORIES
Q4FY24 Earnings: Tata Motors Consolidated Revenue Grows 13.3%; EBITDA Up By 26.6%
Indian Real Estate Market Witnesses Robust Growth Post-COVID: Survey Reveals Consumer Sentiments
US firms, Spend 44 per cent Of Global Company Spending On CSR In India
Cipla's Net Profit Jumps 78.7% To ₹931.87 Crore In Q4
Explore The True Beauty Of Bazaar In Jaipur With The Cultural Luxury Of GT Malls
